IOVA IOVANCE BIOTHERAPEUTICS INC
FollowCOM (common), issuer CIK 1425205
Filings received so far for Q3 2026: 5 13F filers report a position in IOVA shares at 2026-09-30. The quarter is not complete: its 13F deadline is 2026-11-14, and the counts grow as filings arrive.
13D and 13G filers
No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.
Insider trades
No Form 4 transaction on this security in the data.
13F holders, Q3 2026
Filers in the available 13F reports with a share position at 2026-09-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.
| Holder | Shares | Value | % of portfolio | Change | Source |
|---|---|---|---|---|---|
| Mirador Capital Partners LP | 1,095,740 | $16.2M | 1.89% | +15,452 | 13F-HRTimeline |
| GAMMA Investing LLC | 8,987 | $133K | <0.01% | +3,565 | 13F-HRTimeline |
| GK Wealth Management LLC | 7,196 | $107K | 0.06% | new | 13F-HRTimeline |
| Farther Finance Advisors, LLC | 5,694 | $84.4K | <0.01% | -1,399 | 13F-HRTimeline |
| Wealth Enhancement Trust Services, Inc. | 4,000 | $59.3K | 0.01% | -5,404 | 13F-HRTimeline |